company background image
000756 logo

Shandong Xinhua Pharmaceutical SZSE:000756 Stock Report

Last Price

CN¥16.39

Market Cap

CN¥9.1b

7D

0.7%

1Y

-18.5%

Updated

22 Dec, 2024

Data

Company Financials

Shandong Xinhua Pharmaceutical Company Limited

SZSE:000756 Stock Report

Market Cap: CN¥9.1b

000756 Stock Overview

Through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical raw materials in the People's Republic of China, the Americas, Europe, and internationally. More details

000756 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends4/6

Rewards

Price-To-Earnings ratio (8.3x) is below the CN market (36.6x)

Risk Analysis

Unstable dividend track record


My Notes

Capture your thoughts, links and company narrative

Shandong Xinhua Pharmaceutical Company Limited Competitors

Shandong Lukang PharmaceuticalLtd

SHSE:600789

CN¥8.5b

Tianjin Ringpu Bio-TechnologyLtd

SZSE:300119

CN¥8.8b

Guilin Sanjin Pharmaceutical

SZSE:002275

CN¥8.9b

Harbin Pharmaceutical Group

SHSE:600664

CN¥9.9b

Price History & Performance

Summary of share price highs, lows and changes for Shandong Xinhua Pharmaceutical
Historical stock prices
Current Share PriceHK$16.39
52 Week HighHK$20.88
52 Week LowHK$13.45
Beta-0.019
1 Month Change4.39%
3 Month Change15.99%
1 Year Change-18.54%
3 Year Change58.97%
5 Year Change130.85%
Change since IPO91.19%

Recent News & Updates

Recent updates

Shareholder Returns

000756CN PharmaceuticalsCN Market
7D0.7%-1.9%-1.2%
1Y-18.5%-1.8%11.8%

Return vs Industry: 000756 underperformed the CN Pharmaceuticals industry which returned -1.8% over the past year.

Return vs Market: 000756 underperformed the CN Market which returned 11.8% over the past year.

Price Volatility

Is 000756's price volatile compared to industry and market?
000756 volatility
000756 Average Weekly Movement5.8%
Pharmaceuticals Industry Average Movement7.4%
Market Average Movement8.7%
10% most volatile stocks in CN Market12.8%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 000756 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 000756's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19437,064Wenhui Xuwww.xhzy.com

Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical raw materials in the People's Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic drugs; cardiovascular and cerebrovascular drugs; anti-infective drugs and central nervous system, neurological drugs; and other drugs. It engages in the development of real estate business.

Shandong Xinhua Pharmaceutical Company Limited Fundamentals Summary

How do Shandong Xinhua Pharmaceutical's earnings and revenue compare to its market cap?
000756 fundamental statistics
Market capCN¥9.05b
Earnings (TTM)CN¥448.62m
Revenue (TTM)CN¥8.34b

8.3x

P/E Ratio

0.4x

P/S Ratio

Is 000756 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
000756 income statement (TTM)
RevenueCN¥8.34b
Cost of RevenueCN¥6.32b
Gross ProfitCN¥2.01b
Other ExpensesCN¥1.56b
EarningsCN¥448.62m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.66
Gross Margin24.15%
Net Profit Margin5.38%
Debt/Equity Ratio32.5%

How did 000756 perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

42%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 01:46
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shandong Xinhua Pharmaceutical Company Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Alex FanGF Securities (Hong Kong) Brokerage Limited
Ming LiIndustrial Securities Co. Ltd.
Guohe FanPhillip Securities (HK)